Cutaneous reactions to imipramine and chlordiazepoxide.
D000284:Administration, Oral; D000324:Adrenocorticotropic Hormone / Q000009:adverse effects; D000818:Animals; D002707:Chlordiazepoxide / Q000009:adverse effects*; D004342:Drug Hypersensitivity; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D007099:Imipramine / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects; D010787:Photosensitivity Disorders / Q000139:chemically induced; D012867:Skin / Q000187:drug effects; D012871:Skin Diseases / Q000139:chemically induced*; D014581:Urticaria / Q000139:chemically induced
D008996:Monoamine Oxidase Inhibitors; D002707:Chlordiazepoxide; D000324:Adrenocorticotropic Hormone; D007099:Imipramine